Literaturverzeichnis zum Titelthema „Neues aus Laboratoriumsmedizin“
Bayerisches Ärzteblatt 7-8/2011, Seite 394 ff.
Dr. Siegmund Braun
1. AmericanDiabetesAssociation. Diagnosis and classification of diabetes mellitus.
Diabetes Care 2010; 33 Suppl 1:S62-69.
2. Kerner W, Bruckel J. Definition, Classification and Diagnosis of Diabetes mellitus.
Diabetol Stoffwechs 2010; 5:S109-S112.
3. Danne T, Müller-Wieland D, Lackner K, Schleicher E. HBA1c - bisher übliche Einheiten können neben den neuen weiterverwendet werden. Deutsches Ärzteblatt 2009;
106(33):A1633-1634.
4. Jaitner J, Stegherr J, Morath T, Braun S, Bernlochner I, Schomig A, Kastrati A, Sibbing D. Stability of the high on-treatment platelet reactivity phenotype over time in
clopidogrel-treated patients. Thromb Haemost 2011; 105(1):107-112.
5. Mani H, Wolf Z, Lindhoff-Last E. Progress in diagnostic evaluation of platelet function disorders. Hamostaseologie 2010; 30(4):217-229.
6. Sibbing D, Braun S, Morath T, Mehilli J, Vogt W, Schomig A, Kastrati A, von Beckerath N. Platelet Reactivity After Clopidogrel Treatment Assessed With Point-of-Care
Analysis and Early Drug-Eluting Stent Thrombosis. J Am Coll Cardiol 2009; 53(10):849- 856.
7. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction.
Circulation 2007; 116(22):2634-2653.
8. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, Biedert S, Schaub N, Buerge C, Potocki M, Noveanu M, Breidthardt T, Twerenbold R, Winkler K, Bingisser R, Mueller C. Early Diagnosis of Myocardial Infarction with Sensitive Cardiac Troponin Assays. N Engl J Med 2009; 361(9):858-867.
9. Giannitsis E, Becker M, Kurz K, Hess G, Zdunek D, Katus HA. High-Sensitivity Cardiac Troponin T for Early Prediction of Evolving Non-ST-Segment Elevation Myocardial Infarction in Patients with Suspected Acute Coronary Syndrome and Negative Troponin Results on Admission. Clin Chem 2010; 56(4):642-650.
10. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical Validation of a High-Sensitivity Cardiac Troponin T Assay. 2010. p. 254-261.
11. Mills NL, Churchhouse AMD, Lee KK, Anand A, Gamble D, Shah ASV, Paterson E, MacLeod M, Graham C, Walker S, Denvir MA, Fox KAA, Newby DE. Implementation of a Sensitive Troponin I Assay and Risk of Recurrent Myocardial Infarction and Death in Patients With Suspected Acute Coronary Syndrome. 2011. p. 1210-1216.
12. de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, Hashim I, Berry JD, Das SR, Morrow DA, McGuire DK. Association of Troponin T Detected With a Highly Sensitive Assay and Cardiac Structure and Mortality Risk in the General Population. JAMA-J Am Med Assoc 2010; 304(22):2503-2512.
13. Ndrepepa G, Braun S, Mehilli J, Birkmeier KA, Byrne RA, Ott I, Hosl K, Schulz S, Fusaro M, Pache J, Hausleiter J, Laugwitz KL, Massberg S, Seyfarth M, Schomig A, Kastrati A. Prognostic value of sensitive troponin T in patients with stable and unstable angina and undetectable conventional troponin. American Heart Journal 2011; 161(1).
Seite 1 von 2
Literaturverzeichnis zum Titelthema „Neues aus Laboratoriumsmedizin“
Bayerisches Ärzteblatt 7-8/2011, Seite 394 ff.
Dr. Siegmund Braun
Seite 2 von 2
14. Haase M, Haase-Fielitz A. NGAL--From discovery to a new era of "Acute Renal Disease" diagnosis? Clinical Biochemistry 2011; 44(7):499-500.
15. Devarajan P. Review: Neutrophil gelatinase-associated lipocalin: A troponin-like biomarker for human acute kidney injury. Nephrology 2010; 15(4):419-428.
16. Trachtman H, Christen E, Cnaan A, Patrick J, Mai V, Mishra J, Jain A, Bullington N, Devarajan P. Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury. Pediatr Nephrol 2006; 21(7):989-994.
17. Dresse M, Mayr D, Heinemann V, Kahlert S, Bauerfeind I, Nagel D, Seidel D, Stieber P.
Her-2/Neu in Tissue and Serum at Time of Primary Diagnosis of Breast Cancer.
Anticancer Res 2008; 28(6B):33.
18. deVos T, Tetzner R, Model F, Weiss G, Schuster M, Distler J, Steiger KV, Grutzmann R, Pilarsky C, Habermann JK, Fleshner PR, Oubre BM, Day R, Sledziewski AZ, Lofton- Day C. Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer. 2009. p. 1337-1346.
19. Tänzer M, Balluff B, Distler J, Hale K, Leodolter A, Röcken C, Molnar B, Schmid R, Lofton-Day C, Schuster T, Ebert MPA. Performance of Epigenetic Markers SEPT9 and ALX4 in Plasma for Detection of Colorectal Precancerous Lesions. PLoS ONE 2010;
5(2):e9061.
20. Suhre K, Wallaschofski H, Raffler J, Friedrich N, Haring R, Michael K, Wasner C, Krebs A, Kronenberg F, Chang D, Meisinger C, Wichmann HE, Hoffmann W, Volzke H, Volker U, Teumer A, Biffar R, Kocher T, Felix SB, Illig T, Kroemer HK, Gieger C, Romisch- Margl W, Nauck M. A genome-wide association study of metabolic traits in human urine. Nature Genetics 2011; 43(6):565-569.
21. Carbonnelle E, Mesquita C, Bille E, Day N, Dauphin B, Beretti J-L, Ferroni A, Gutmann L, Nassif X. MALDI-TOF mass spectrometry tools for bacterial identification in clinical microbiology laboratory. Clinical Biochemistry 2011; 44(1):104-109.
22. Lippi G, Guidi GC. Risk management in the preanalytical phase of laboratory testing.
Clin Chem Lab Med 2007; 45(6):720-727.
23. Bundesärztekammer. Richtlinie der Bundesärztekammer zur Qualitätssicherung laboratoriumsmedizinischer Untersuchungen. Deutsches Ärzteblatt 2008; 105(7):A341- A355.
24. Bundesärztekammer. B 4 Ejakulatuntersuchungen. Deutsches Ärzteblatt 2011; 106(1- 2):A55-A58.
25. Brüggemann M. Neue Richtlinie zu labormedizinischen Untersuchungen. Deutsches Ärzteblatt 2008; 105(13):A677-678.
26. Thygesen K, Mair J, Katus H, Plebani M, Venge P, Collinson P, Lindahl B, Giannitsis E, Hasin Y, Galvani M, Tubaro M, Alpert JS, Biasucci LM, Koenig W, Mueller C, Huber K, Hamm C, Jaffe AS. Recommendations for the use of cardiac troponin measurement in acute cardiac care. 2010. p. 2197-2204.
